94 results
Page 4 of 5
S-4/A
EX-8.1
5ue3ypwwjx6tszbzyz2
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
hzg2ga z8ygc4kh
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
k5y64wqwm8wt9cd7
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.11
130vfowr
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
aumz2 dk9wz0bl
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
h8499g1x1
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
td5xv4hp
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
sufg0
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
d2c0moy82gl47bl
15 Mar 21
Business combination disclosure
8:20am
8-K
6ihooi8rrtsem v80
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
l97 1und6zr9apqdu09p
5 Mar 21
Annual report
8:13am
10-Q
84f7np52wza iz7hy
20 Aug 20
Quarterly report
4:15pm
8-K
EX-99.1
l6xf jmla
16 Jul 20
Report of Independent Registered Public Accounting Firm
4:30pm
8-K
EX-10.2
9vzyg466eq7z66ba
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm